MedTrace Logo

Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence

NCT00693420 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 278

Last updated 2013-10-30

Study results available
· View outcomes & findings →

Summary

This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.

Conditions

  • Eyelashes

Interventions

DRUG

Bimatoprost 0.03% sterile solution

Apply one drop of study medication using single-use per eye applicator to upper eyelid margin once daily.

DRUG

vehicle sterile solution

Apply one drop of study medication using single-use per eye applicator to upper eyelid margin once daily

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2007-10-31
Completion
2007-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00693420 on ClinicalTrials.gov